Symbols / TXMD Stock $2.10 +1.45% TherapeuticsMD, Inc.
TXMD (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Ratings
Current target
$2.10
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-08-17 | reit | Cantor Fitzgerald | Neutral → Neutral | $5 |
| 2022-07-13 | reit | Cantor Fitzgerald | — → Neutral | $1 |
| 2022-06-07 | down | HC Wainwright & Co. | Buy → Neutral | $10 |
- TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch ue, 28 Apr 2026 21
- TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading. - Stock Community Signals - Cổng thông tin điện tử tỉnh Tây Ninh hu, 23 Apr 2026 05
- TXMD (TherapeuticsMD Inc.) Q3 2023 EPS misses consensus estimates by wide margin as shares dip 0.48 percent in today's trading. - Shared Momentum Picks - UBND thành phố Hải Phòng Wed, 22 Apr 2026 20
- [SCHEDULE 13G] TherapeuticsMD, Inc. Passive Investment Disclosure (>5%) - Stock Titan Mon, 06 Apr 2026 07
- TXMD (TherapeuticsMD) shares gain 5.8 percent despite wider than expected Q3 2023 per share loss. - Current Ratio - Cổng thông tin điện tử tỉnh Lào Cai hu, 23 Apr 2026 00
- How Low Can TherapeuticsMD Stock Really Go? - Trefis Sun, 21 Dec 2025 08
- TXMD Should I Buy - Intellectia AI Wed, 08 Apr 2026 19
- TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch Mon, 27 Apr 2026 21
- TherapeuticsMD Explains Brief Delay In Annual Filing - TipRanks Wed, 01 Apr 2026 07
- symbol__ Stock Quote Price and Forecast - CNN Wed, 30 Aug 2023 09
- TXMD (TherapeuticsMD Inc.) Q3 2023 EPS misses consensus estimates by wide margin as shares dip 0.48 percent in today's trading. - Trending Stock Ideas - Cổng thông tin điện tử tỉnh Tây Ninh Wed, 22 Apr 2026 23
- TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading. - Expansion Phase - Cổng thông tin điện tử tỉnh Lào Cai hu, 23 Apr 2026 03
- TherapeuticsMD (NASDAQ: TXMD) files 2025 Form 10-K after printer error - Stock Titan ue, 31 Mar 2026 07
- TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy - TipRanks Mon, 30 Mar 2026 07
- TXMD Forecast — Price Prediction for 2026. Should I Buy TXMD? - Intellectia AI Sat, 31 May 2025 12
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
3.02
+71.61%
|
1.76
+35.25%
|
1.30
-98.14%
|
69.96
|
| Operating Revenue |
|
3.02
+71.61%
|
1.76
+35.25%
|
1.30
-98.14%
|
69.96
|
| Cost Of Revenue |
|
—
|
—
|
0.00
-100.00%
|
1.40
|
| Reconciled Cost Of Revenue |
|
—
|
—
|
0.02
-98.42%
|
1.39
|
| Gross Profit |
|
—
|
—
|
1.30
-98.10%
|
68.57
|
| Operating Expense |
|
7.24
+9.55%
|
6.61
-32.77%
|
9.82
-83.03%
|
57.90
|
| Research And Development |
|
—
|
—
|
—
|
0.00
|
| Selling General And Administration |
|
6.85
+12.40%
|
6.10
-31.53%
|
8.90
-84.30%
|
56.71
|
| Selling And Marketing Expense |
|
—
|
—
|
—
|
0.00
|
| General And Administrative Expense |
|
6.85
+12.40%
|
6.10
|
—
|
57.90
|
| Other Gand A |
|
6.85
+12.40%
|
6.10
|
—
|
57.90
|
| Total Expenses |
|
7.24
+9.55%
|
6.61
-32.77%
|
9.82
-83.43%
|
59.30
|
| Operating Income |
|
-4.21
+13.01%
|
-4.84
+43.17%
|
-8.52
-179.93%
|
10.66
|
| Total Operating Income As Reported |
|
-4.39
+28.17%
|
-6.11
+28.29%
|
-8.52
-815.62%
|
1.19
|
| EBITDA |
|
-3.02
+15.24%
|
-3.56
+53.11%
|
-7.60
-164.07%
|
11.86
|
| Normalized EBITDA |
|
-2.85
-23.91%
|
-2.30
+69.79%
|
-7.60
-135.63%
|
21.34
|
| Reconciled Depreciation |
|
1.19
-6.80%
|
1.28
+38.83%
|
0.92
-23.17%
|
1.20
|
| EBIT |
|
-4.21
+13.01%
|
-4.84
+43.17%
|
-8.52
-179.93%
|
10.66
|
| Total Unusual Items |
|
-0.18
+86.12%
|
-1.27
|
0.00
+100.00%
|
-9.47
|
| Total Unusual Items Excluding Goodwill |
|
-0.18
+86.12%
|
-1.27
|
0.00
+100.00%
|
-9.47
|
| Special Income Charges |
|
-0.18
+86.12%
|
-1.27
|
0.00
+100.00%
|
-9.47
|
| Impairment Of Capital Assets |
|
0.18
-86.12%
|
1.27
|
0.00
|
—
|
| Restructuring And Mergern Acquisition |
|
—
|
—
|
0.00
-100.00%
|
9.47
|
| Net Income |
|
-0.57
+73.91%
|
-2.18
+78.78%
|
-10.28
-109.18%
|
112.00
|
| Pretax Income |
|
-0.65
+72.13%
|
-2.34
+69.74%
|
-7.74
-820.86%
|
1.07
|
| Net Non Operating Interest Income Expense |
|
0.14
+5.19%
|
0.14
|
—
|
—
|
| Interest Expense Non Operating |
|
—
|
—
|
—
|
—
|
| Net Interest Income |
|
0.14
+5.19%
|
0.14
|
—
|
—
|
| Interest Expense |
|
—
|
—
|
—
|
—
|
| Interest Income Non Operating |
|
0.14
+5.19%
|
0.14
|
—
|
—
|
| Interest Income |
|
0.14
+5.19%
|
0.14
|
—
|
—
|
| Other Income Expense |
|
3.42
+44.51%
|
2.37
+202.94%
|
0.78
+108.14%
|
-9.59
|
| Other Non Operating Income Expenses |
|
3.60
-1.07%
|
3.63
+365.30%
|
0.78
+767.52%
|
-0.12
|
| Tax Provision |
|
0.00
+100.00%
|
-0.03
+27.91%
|
-0.04
|
0.00
|
| Tax Rate For Calcs |
|
0.00
-100.00%
|
0.00
+164.62%
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
+100.00%
|
-0.02
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-0.57
+73.91%
|
-2.18
+78.78%
|
-10.28
-109.18%
|
112.00
|
| Net Income From Continuing Operation Net Minority Interest |
|
-0.65
+71.76%
|
-2.31
+69.97%
|
-7.70
-816.85%
|
1.07
|
| Net Income From Continuing And Discontinued Operation |
|
-0.57
+73.91%
|
-2.18
+78.78%
|
-10.28
-109.18%
|
112.00
|
| Net Income Continuous Operations |
|
-0.65
+71.76%
|
-2.31
+69.97%
|
-7.70
-816.85%
|
1.07
|
| Net Income Discontinuous Operations |
|
0.08
-35.88%
|
0.13
+105.08%
|
-2.58
-102.33%
|
110.92
|
| Normalized Income |
|
-0.48
+55.03%
|
-1.06
+86.22%
|
-7.70
-173.00%
|
10.55
|
| Net Income Common Stockholders |
|
-0.57
+73.91%
|
-2.18
+78.78%
|
-10.28
-109.18%
|
112.00
|
| Diluted EPS |
|
—
|
-0.19
+80.61%
|
-0.98
-108.19%
|
11.96
|
| Basic EPS |
|
—
|
-0.19
+80.61%
|
-0.98
-107.90%
|
12.41
|
| Basic Average Shares |
|
—
|
11.53
+10.45%
|
10.44
+15.65%
|
9.03
|
| Diluted Average Shares |
|
—
|
11.53
+10.45%
|
10.44
+11.48%
|
9.37
|
| Diluted NI Availto Com Stockholders |
|
-0.57
+73.91%
|
-2.18
+78.78%
|
-10.28
-109.18%
|
112.00
|
| Depreciation Amortization Depletion Income Statement |
|
0.38
-24.56%
|
0.51
-44.79%
|
0.92
-22.72%
|
1.19
|
| Depreciation And Amortization In Income Statement |
|
0.38
-24.56%
|
0.51
-44.79%
|
0.92
-22.72%
|
1.19
|
| Total Other Finance Cost |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
37.66
-3.00%
|
38.82
-10.36%
|
43.31
-52.12%
|
90.46
|
| Current Assets |
|
14.45
+17.83%
|
12.26
+3.93%
|
11.80
-78.69%
|
55.35
|
| Cash Cash Equivalents And Short Term Investments |
|
7.48
+47.91%
|
5.06
+16.92%
|
4.33
-88.63%
|
38.07
|
| Cash And Cash Equivalents |
|
7.48
+47.91%
|
5.06
+16.92%
|
4.33
-88.63%
|
38.07
|
| Cash Financial |
|
—
|
—
|
—
|
38.07
|
| Receivables |
|
3.52
-1.04%
|
3.56
+15.28%
|
3.09
|
0.00
|
| Accounts Receivable |
|
—
|
—
|
—
|
—
|
| Gross Accounts Receivable |
|
—
|
—
|
—
|
—
|
| Allowance For Doubtful Accounts Receivable |
|
—
|
—
|
—
|
—
|
| Other Receivables |
|
3.52
-1.04%
|
3.56
+15.28%
|
3.09
|
—
|
| Inventory |
|
—
|
—
|
—
|
—
|
| Raw Materials |
|
—
|
—
|
—
|
—
|
| Work In Process |
|
—
|
—
|
—
|
—
|
| Finished Goods |
|
—
|
—
|
—
|
—
|
| Prepaid Assets |
|
—
|
—
|
0.25
-78.32%
|
1.17
|
| Restricted Cash |
|
—
|
—
|
0.00
-100.00%
|
11.25
|
| Assets Held For Sale Current |
|
—
|
0.00
-100.00%
|
0.34
|
0.00
|
| Other Current Assets |
|
3.44
-5.53%
|
3.64
-9.84%
|
4.04
-33.13%
|
6.03
|
| Total Non Current Assets |
|
23.21
-12.62%
|
26.56
-15.71%
|
31.51
-10.24%
|
35.11
|
| Net PPE |
|
5.29
-13.26%
|
6.10
-11.22%
|
6.87
-10.25%
|
7.66
|
| Gross PPE |
|
5.29
-13.26%
|
6.10
-11.22%
|
6.87
-31.97%
|
10.10
|
| Accumulated Depreciation |
|
—
|
—
|
-2.52
-3.15%
|
-2.44
|
| Properties |
|
—
|
—
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
—
|
—
|
2.47
-0.04%
|
2.47
|
| Other Properties |
|
5.29
-13.26%
|
6.10
-11.22%
|
6.87
-9.33%
|
7.58
|
| Leases |
|
—
|
—
|
0.05
+0.00%
|
0.05
|
| Goodwill And Other Intangible Assets |
|
3.76
-12.96%
|
4.32
-29.14%
|
6.10
-12.17%
|
6.94
|
| Other Intangible Assets |
|
3.76
-12.96%
|
4.32
-29.14%
|
6.10
-12.17%
|
6.94
|
| Non Current Accounts Receivable |
|
13.71
-14.35%
|
16.01
-13.38%
|
18.48
-8.73%
|
20.25
|
| Other Non Current Assets |
|
0.44
+241.54%
|
0.13
+124.14%
|
0.06
-77.08%
|
0.25
|
| Total Liabilities Net Minority Interest |
|
10.78
-5.87%
|
11.45
-18.33%
|
14.02
-74.65%
|
55.31
|
| Current Liabilities |
|
4.79
-7.38%
|
5.17
-24.63%
|
6.85
-85.37%
|
46.84
|
| Payables And Accrued Expenses |
|
1.14
+51.99%
|
0.75
-55.42%
|
1.69
-90.93%
|
18.61
|
| Payables |
|
0.38
+46.12%
|
0.26
+855.56%
|
0.03
-98.75%
|
2.16
|
| Accounts Payable |
|
0.38
+46.12%
|
0.26
+855.56%
|
0.03
-98.75%
|
2.16
|
| Current Accrued Expenses |
|
0.77
+55.06%
|
0.49
-70.24%
|
1.66
-89.91%
|
16.45
|
| Current Debt And Capital Lease Obligation |
|
0.97
-40.29%
|
1.63
+10.86%
|
1.47
+5.97%
|
1.39
|
| Current Debt |
|
—
|
—
|
—
|
—
|
| Other Current Borrowings |
|
—
|
—
|
—
|
—
|
| Current Capital Lease Obligation |
|
0.97
-40.29%
|
1.63
+10.86%
|
1.47
+5.97%
|
1.39
|
| Current Deferred Liabilities |
|
—
|
—
|
0.00
-100.00%
|
1.01
|
| Other Current Liabilities |
|
2.67
-4.10%
|
2.78
-24.72%
|
3.69
-85.70%
|
25.83
|
| Total Non Current Liabilities Net Minority Interest |
|
6.00
-4.63%
|
6.29
-12.30%
|
7.17
-15.43%
|
8.48
|
| Long Term Debt And Capital Lease Obligation |
|
5.12
-7.58%
|
5.54
-15.16%
|
6.53
-11.36%
|
7.37
|
| Long Term Capital Lease Obligation |
|
5.12
-7.58%
|
5.54
-15.16%
|
6.53
-11.36%
|
7.37
|
| Other Non Current Liabilities |
|
0.87
+17.34%
|
0.74
+16.98%
|
0.64
-42.55%
|
1.11
|
| Stockholders Equity |
|
26.88
-1.80%
|
27.37
-6.55%
|
29.29
-16.66%
|
35.14
|
| Common Stock Equity |
|
26.88
-1.80%
|
27.37
-6.55%
|
29.29
-16.66%
|
35.14
|
| Capital Stock |
|
0.01
+0.00%
|
0.01
+0.00%
|
0.01
+22.22%
|
0.01
|
| Common Stock |
|
0.01
+0.00%
|
0.01
+0.00%
|
0.01
+22.22%
|
0.01
|
| Preferred Stock |
|
—
|
—
|
—
|
0.00
|
| Share Issued |
|
11.57
+0.36%
|
11.53
0.00%
|
11.53
+21.42%
|
9.50
|
| Ordinary Shares Number |
|
11.57
+0.36%
|
11.53
0.00%
|
11.53
+21.42%
|
9.50
|
| Additional Paid In Capital |
|
979.26
+0.01%
|
979.18
+0.03%
|
978.92
+0.45%
|
974.50
|
| Retained Earnings |
|
-952.39
-0.06%
|
-951.82
-0.23%
|
-949.64
-1.09%
|
-939.36
|
| Total Equity Gross Minority Interest |
|
26.88
-1.80%
|
27.37
-6.55%
|
29.29
-16.66%
|
35.14
|
| Total Capitalization |
|
26.88
-1.80%
|
27.37
-6.55%
|
29.29
-16.66%
|
35.14
|
| Working Capital |
|
9.66
+36.19%
|
7.09
+43.52%
|
4.94
-41.94%
|
8.51
|
| Invested Capital |
|
26.88
-1.80%
|
27.37
-6.55%
|
29.29
-16.66%
|
35.14
|
| Total Debt |
|
6.10
-15.02%
|
7.17
-10.37%
|
8.01
-8.61%
|
8.76
|
| Net Debt |
|
—
|
—
|
—
|
—
|
| Capital Lease Obligations |
|
6.10
-15.02%
|
7.17
-10.37%
|
8.01
-8.61%
|
8.76
|
| Net Tangible Assets |
|
23.11
+0.29%
|
23.05
-0.60%
|
23.19
-17.77%
|
28.20
|
| Tangible Book Value |
|
23.11
+0.29%
|
23.05
-0.60%
|
23.19
-17.77%
|
28.20
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
2.45
+109.74%
|
1.17
+105.07%
|
-23.08
-346.62%
|
9.36
|
| Cash Flow From Continuing Operating Activities |
|
2.45
+109.74%
|
1.17
+105.07%
|
-23.08
-346.43%
|
9.37
|
| Cash From Discontinued Operating Activities |
|
—
|
—
|
—
|
-13.44
|
| Net Income From Continuing Operations |
|
-0.65
+71.76%
|
-2.31
+69.97%
|
-7.70
-816.85%
|
1.07
|
| Depreciation Amortization Depletion |
|
1.19
-6.80%
|
1.28
+38.83%
|
0.92
-23.17%
|
1.20
|
| Depreciation |
|
1.19
-6.80%
|
1.28
+1180.00%
|
0.10
-83.33%
|
0.60
|
| Amortization Cash Flow |
|
—
|
—
|
0.80
+33.33%
|
0.60
|
| Depreciation And Amortization |
|
1.19
-6.80%
|
1.28
+38.83%
|
0.92
-23.17%
|
1.20
|
| Amortization Of Intangibles |
|
—
|
—
|
0.80
+33.33%
|
0.60
|
| Other Non Cash Items |
|
—
|
-0.22
-69.77%
|
-0.13
+67.83%
|
-0.40
|
| Stock Based Compensation |
|
0.07
-71.59%
|
0.26
-79.23%
|
1.27
-89.02%
|
11.57
|
| Provisionand Write Offof Assets |
|
—
|
—
|
—
|
—
|
| Asset Impairment Charge |
|
0.18
-86.12%
|
1.27
|
0.00
|
—
|
| Change In Working Capital |
|
1.66
+148.21%
|
0.67
+103.84%
|
-17.45
-326.97%
|
-4.09
|
| Change In Receivables |
|
—
|
—
|
—
|
—
|
| Changes In Account Receivables |
|
—
|
—
|
—
|
—
|
| Change In Inventory |
|
—
|
—
|
—
|
—
|
| Change In Prepaid Assets |
|
0.20
-49.37%
|
0.40
-80.14%
|
2.00
+222.42%
|
0.62
|
| Change In Payables And Accrued Expense |
|
0.39
+150.45%
|
-0.78
+95.66%
|
-17.85
-684.99%
|
3.05
|
| Change In Accrued Expense |
|
0.27
+127.04%
|
-1.01
+93.60%
|
-15.71
-468.68%
|
4.26
|
| Change In Payable |
|
0.12
-48.48%
|
0.23
+110.82%
|
-2.13
-76.30%
|
-1.21
|
| Change In Account Payable |
|
0.12
-48.48%
|
0.23
+110.82%
|
-2.13
-76.30%
|
-1.21
|
| Change In Other Current Assets |
|
2.02
+4.66%
|
1.93
+271.40%
|
-1.13
+85.25%
|
-7.64
|
| Change In Other Current Liabilities |
|
-0.95
-7.60%
|
-0.88
-87.26%
|
-0.47
-289.26%
|
-0.12
|
| Investing Cash Flow |
|
—
|
—
|
0.00
+100.00%
|
-0.35
|
| Cash Flow From Continuing Investing Activities |
|
—
|
—
|
0.00
+100.00%
|
-0.35
|
| Cash From Discontinued Investing Activities |
|
—
|
—
|
—
|
223.83
|
| Net PPE Purchase And Sale |
|
—
|
—
|
—
|
0.00
|
| Purchase Of PPE |
|
—
|
—
|
—
|
0.00
|
| Capital Expenditure |
|
—
|
—
|
—
|
-0.35
|
| Net Intangibles Purchase And Sale |
|
—
|
—
|
0.00
+100.00%
|
-0.35
|
| Purchase Of Intangibles |
|
—
|
—
|
—
|
-0.35
|
| Financing Cash Flow |
|
—
|
0.00
-100.00%
|
3.15
+101.34%
|
-235.21
|
| Cash Flow From Continuing Financing Activities |
|
—
|
0.00
-100.00%
|
3.15
+101.34%
|
-235.21
|
| Net Issuance Payments Of Debt |
|
—
|
—
|
0.00
+100.00%
|
-219.43
|
| Issuance Of Debt |
|
—
|
—
|
—
|
—
|
| Repayment Of Debt |
|
—
|
—
|
0.00
+100.00%
|
-219.43
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Long Term Debt Payments |
|
—
|
—
|
0.00
+100.00%
|
-219.43
|
| Net Long Term Debt Issuance |
|
—
|
—
|
0.00
+100.00%
|
-219.43
|
| Short Term Debt Payments |
|
—
|
—
|
—
|
-219.43
|
| Net Short Term Debt Issuance |
|
—
|
—
|
—
|
-219.43
|
| Net Common Stock Issuance |
|
—
|
0.00
-100.00%
|
3.15
+27.67%
|
2.47
|
| Repurchase Of Capital Stock |
|
—
|
—
|
0.00
+100.00%
|
-38.66
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
—
|
0.00
|
| Net Other Financing Charges |
|
—
|
—
|
—
|
-1.27
|
| Changes In Cash |
|
2.42
+231.15%
|
0.73
+101.63%
|
-44.99
-184.66%
|
-15.80
|
| Beginning Cash Position |
|
5.06
+16.92%
|
4.33
-91.23%
|
49.32
-24.27%
|
65.12
|
| End Cash Position |
|
7.48
+47.91%
|
5.06
+16.92%
|
4.33
-91.23%
|
49.32
|
| Free Cash Flow |
|
2.45
+109.74%
|
1.17
+105.07%
|
-23.08
-356.34%
|
9.00
|
| Interest Paid Supplemental Data |
|
—
|
—
|
0.00
-100.00%
|
13.54
|
| Common Stock Issuance |
|
—
|
0.00
-100.00%
|
3.15
+27.67%
|
2.47
|
| Issuance Of Capital Stock |
|
—
|
0.00
-100.00%
|
3.15
-86.95%
|
24.15
|
| Net Preferred Stock Issuance |
|
—
|
—
|
0.00
+100.00%
|
-16.97
|
| Preferred Stock Issuance |
|
—
|
—
|
0.00
-100.00%
|
21.68
|
| Preferred Stock Payments |
|
—
|
—
|
0.00
+100.00%
|
-38.66
|
| Cash Flow From Discontinued Operation |
|
-0.03
+93.15%
|
-0.44
+98.25%
|
-25.06
-111.91%
|
210.40
|
| Cash From Discontinued Financing Activities |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-03-30 View
- 10-K2026-03-30 View
- 8-K2026-01-21 View
- 42025-12-29 View
- 8-K2025-12-16 View
- 8-K2025-11-13 View
- 10-Q2025-11-12 View
- 42025-11-05 View
- 42025-11-05 View
- 42025-11-05 View
- 42025-11-05 View
- 10-Q2025-08-12 View
- 8-K2025-08-12 View
- 10-Q2025-05-13 View
- 8-K2025-05-13 View
- 42025-04-15 View
- 42025-04-15 View
- 42025-04-10 View
- 8-K2025-04-09 View
- 10-K2025-03-27 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|